Chemed Corporation (NYSE: CHE) files Form 144 for 1,500-share resale

Rhea-AI Filing Summary

Chemed Corporation filed a Form 144 notifying a proposed sale of 1,500 shares of Common stock. The notice lists Merrill Lynch as the broker and an effective filing date of 03/27/2026. The filing also records two reported sales by Kevin McNamara of 1,000 shares each on 03/12/2026.

Insights

Securities Compliance Attorney

Routine Form 144 notice of proposed resale by an insider and recent small sales.

Form 144 lists a proposed sale of 1,500 common shares with 03/27/2026 as the filing date and identifies Merrill Lynch as the broker. The document also records two prior dispositions of 1,000 shares each on 03/12/2026 by Kevin McNamara.

The filing is procedural: it notifies the SEC and market intermediary of intended resale under applicable exemptions. Cash‑flow treatment and resale method details are limited to broker identification; subsequent transaction notices or Form 4/Form 5 filings may provide further settlement details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 5905 E. Galbraith Rd Suite 7000 Cincinnati OH 45236	1500	558855	13765136	03/27/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/16/2024	Stock Award	Chemed Corporation			1496	02/16/2024	Stock Exercise
Common	08/02/2024	Stock Award	Chemed Corporation			4	08/02/2024	Stock Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin McNamara 255 E. 5th St. Suite 2600 Cincinnati OH 45202	Chemed Corporation	03/12/2026	1000	402050
Kevin McNamara 255 E. 5th St. Suite 2600 Cincinnati OH 45202	Chemed Corporation	03/12/2026	1000	404244

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Chemed's (CHE) Form 144 report?

It reports a proposed resale of 1,500 shares of Common stock and lists Merrill Lynch as broker. The filing date shown is 03/27/2026, with broker and security-class details provided in the notice.

Who reported recent share sales in the filing for CHE?

The filing records Kevin McNamara as reporting two sales of 1,000 shares each on 03/12/2026. The entries appear in the "Securities Sold During The Past 3 Months" section of the notice.

Does the Form 144 show how proceeds will be used by Chemed (CHE)?

No. The notice identifies a proposed resale and broker but does not state the use of proceeds. Form 144s typically notify resale intent; specific proceeds treatment is not detailed in this excerpt.

Is the 1,500-share amount in Chemed's Form 144 an executed sale?

No. The filing shows a proposed resale of 1,500 shares as of 03/27/2026. Form 144s notify intent to sell under exemptions and do not by themselves confirm completed settlement.

Will Chemed (CHE) file additional forms after the resale?

Possibly. Completed transactions by insiders are typically reported on Form 4 or Form 5. This Form 144 shows proposed resale; subsequent filings would disclose executed transactions and post-transaction holdings.